Carbon Ion Radiotherapy for Oligo-Recurrence in the Lung
Authors:
Open Access
- 27 January 2013
- journal article
- research article
- Published by Hindawi Limited in Pulmonary Medicine
- Vol. 2013, 1-6
Abstract
The clinical results after carbon ion radiotherapy for the metastatic lung tumors believed to be in the state of oligo-recurrence were evaluated. One hundred and sixteen lesions in 91 patients with lung cancer metastasis were treated with carbon ion radiotherapy at our institute from April 1997 to February 2011. Regarding the prescribed dose, total dose ranged between 40 gray equivalents (GyE) and 80 GyE, and fraction size ranged from 1 to 16 fractions. After a median followup period of 2.3 years (range, 0.3–13.1 years), the statistical overall survival rate and local control rate were 71.2% and 91.9% at 2 years after treatment, respectively. Treatment-related side effects were not a clinical problem. When classified by the primary organ, there were 49 cases of lung cancer, 20 cases of colorectal cancer, and 22 cases of others. The overall survival rate and local control rate for lung metastasis cases from lung cancer at 2 years after treatment were 81.5% and 92.4%, respectively, and 65.0% and 92.0% regarding lung metastasis from colorectal cancer. Carbon ion beam therapy for the metastatic lung tumors is a safe therapy, and the therapeutic effect is comparable to the outcome obtained from reported surgical resections.Keywords
This publication has 13 references indexed in Scilit:
- A Review of Update Clinical Results of Carbon Ion RadiotherapyJapanese Journal of Clinical Oncology, 2012
- Stereotactic body radiation therapy for lung metastasesLung Cancer, 2012
- Proton Beam Therapy for Patients With Medically Inoperable Stage I Non–Small-Cell Lung Cancer at the University of TsukubaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Stereotactic body radiation therapy for early stage non-small cell lung cancer: Results of a prospective trialLung Cancer, 2010
- Oligometastases and Oligo-recurrence: The New Era of Cancer TherapyJapanese Journal of Clinical Oncology, 2010
- Outcome in a Prospective Phase II Trial of Medically Inoperable Stage I Non–Small-Cell Lung Cancer Patients Treated With Stereotactic Body RadiotherapyJournal of Clinical Oncology, 2009
- Stereotactic Body Radiotherapy for Oligometastatic Lung TumorsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- A prospective pilot study of curative‐intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesionsCancer, 2007
- Carbon Ion Radiotherapy for Stage I Non-small Cell Lung Cancer Using a Regimen of Four Fractions during 1 WeekJournal of Thoracic Oncology, 2007
- Curative treatment of Stage I non–small-cell lung cancer with carbon ion beams using a hypofractionated regimenInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007